Fridays is a telehealth platform offering personalized GLP-1 weight loss programs from home. The service combines compounded semaglutide and tirzepatide with clinical support, dietitian coaching, and lab work. Pricing starts at $129 per month with medications included.
Fridays stands out for its streamlined onboarding, microdosing protocols for side effect reduction, and 1,000+ five-star TrustPilot reviews. The platform serves adults with a BMI of 25 or higher and uses licensed board-certified physicians for all prescriptions. Insurance is not accepted, but HSA and FSA funds can be applied.
This review covers how Fridays works, what medications it prescribes, what real users say, and whether the cost justifies the GLP-1 program compared to alternatives.
What Is Fridays?
Fridays is a telehealth weight loss platform that provides GLP-1 medications, clinical oversight, and lifestyle coaching through an online-only care model starting at $129 per month. The company specializes in compounded semaglutide and tirzepatide — the active compounds in Ozempic/Wegovy and Mounjaro/Zepbound respectively. Fridays positions itself as a full-service weight care clinic accessible from home.
The platform operates nationwide in the United States. Eligible patients access care through video consultations with licensed providers. Medications are shipped directly to the patient’s door after clinical approval.
Fridays was reviewed and recognized by outlets including Forbes and Yahoo Lifestyle. The company has accumulated over 1,000 five-star reviews on TrustPilot. Customer service response time under 10 minutes is cited as a distinguishing factor in independent reviews.
What Fridays includes in every plan:
- GLP-1 medication (compounded semaglutide or tirzepatide)
- Unlimited video visits with licensed providers
- Unlimited lab work
- 1-on-1 dietitian and mental health coach
- SESH fitness app membership
- Support group access
How Does Fridays Work?
Fridays operates as a direct-to-patient telehealth service — patients complete an online health assessment, consult with a licensed provider via video, and receive GLP-1 medications by mail if approved. The onboarding process is designed to be completed entirely online without in-person clinic visits. Board-certified physicians review patient history and determine clinical eligibility.
After approval, the provider customizes a medication plan based on BMI, health history, and weight loss goals. Dose adjustments happen through ongoing video consultations. The care team monitors progress and adjusts the regimen as needed throughout the program.
Fridays includes lab work with every plan. Laboratory testing confirms baseline metabolic markers before treatment begins. Ongoing labs track progress and flag any concerns that require medical attention.
What Medications Does Fridays Prescribe?
Fridays prescribes compounded versions of semaglutide (GLP-1) and tirzepatide (GLP-1/GIP dual agonist) — the same active compounds found in Ozempic, Wegovy, Mounjaro, and Zepbound. Compounded formulations are prepared by licensed compounding pharmacies and are not FDA-approved branded drugs. They contain the same active ingredient at a lower cost than brand-name alternatives.
Semaglutide mimics the GLP-1 hormone to suppress appetite and slow gastric emptying. Tirzepatide activates both GLP-1 and GIP receptors, producing stronger metabolic effects and greater weight loss in clinical trials. Fridays providers match the appropriate medication to each patient’s clinical profile.
The platform also offers microdosing protocols for patients who cannot tolerate standard starting doses. Microdosing begins at sub-therapeutic levels and increases gradually. This approach reduces early GI side effects while allowing the body to adjust to the medication.
How Does Fridays Weight Loss Program Work?
The Fridays program combines GLP-1 medication management with structured lifestyle coaching — appetite suppression from the medication works alongside dietitian-designed nutrition plans and fitness support. The medical and lifestyle components run simultaneously from day one. Patients receive medication, coaching, and clinical oversight as a bundled service.
In fact, the program design addresses a gap in standard GLP-1 prescriptions. Most telehealth platforms send medications without lifestyle support. Fridays integrates a dietitian, mental health coach, and fitness app into the same monthly fee — reducing the need to seek additional coaching elsewhere.
Progress is monitored through regular video consultations. Providers adjust dose, assess side effects, and review labs at scheduled intervals. Patients who experience side effects or plateau on a given dose can escalate or adjust their regimen through the same video visit system.
What Is the Onboarding Process?
The Fridays onboarding process requires completing an online health intake form, scheduling a video consultation with a licensed provider, and receiving a prescription decision before medications ship. The intake form captures medical history, current medications, BMI, and weight loss goals. The provider uses this information to assess clinical eligibility.
Adults with a BMI of 25 or higher are the primary eligible population. Patients with contraindications to GLP-1 medications — including a history of medullary thyroid carcinoma or MEN2 syndrome — are not approved. The clinical screening process is conducted by board-certified physicians.
After approval, compounded medications ship directly to the patient. Shipping timelines vary by location and pharmacy processing time. Most patients receive their first shipment within 5-7 business days of provider approval.
Does Fridays Offer Microdosing?
Yes. Fridays offers personalized microdosing protocols — starting GLP-1 medications at sub-therapeutic doses to reduce side effects and improve tolerance before escalating to full therapeutic levels. Microdosing is a clinically recognized approach to reducing early GI side effects from GLP-1 medications. Nausea, vomiting, and diarrhea are less severe when the body adjusts gradually to the drug’s effect on gastric motility.
The microdosing schedule is customized to each patient. Providers determine the starting dose and escalation schedule based on individual tolerance and health history. Patients who cannot tolerate standard titration find microdosing a significant differentiator compared to programs that only offer fixed-dose protocols.
Fridays explicitly lists microdosing as a program feature — unlike many competing telehealth platforms that use standard escalation schedules without flexibility. This patient-centered approach is frequently cited in positive reviews as a reason users stayed on the program after struggling with side effects elsewhere.
What Are the Benefits of Fridays?
Fridays delivers GLP-1 weight loss medications with full clinical support, lab work, and lifestyle coaching bundled into a single monthly fee starting at $129 — a competitive all-in-one price point for the telehealth GLP-1 market. The inclusive pricing contrasts with platforms that charge separately for consultations, labs, and medications. Fridays’ flat fee covers all core program components.
The care model addresses both biological and behavioral weight loss factors. GLP-1 medications reduce appetite at the physiological level. Dietitian coaching and mental health support address eating behaviors and psychological drivers of weight gain.
Here’s what stands out: the 1-on-1 coaching access separates Fridays from medication-only platforms. Many GLP-1 telehealth services function as prescription delivery services with minimal clinical engagement. Fridays maintains ongoing relationships with patients through unlimited video visits and coaching sessions.
How Much Weight Can You Lose with Fridays?
Weight loss outcomes on Fridays depend on the prescribed medication — patients on compounded tirzepatide typically achieve greater weight loss than those on semaglutide, reflecting the clinical superiority of tirzepatide in head-to-head trials. SURMOUNT clinical trials showed tirzepatide producing 15-22% body weight reduction over 72 weeks. Semaglutide trials (STEP program) showed 10-15% body weight reduction in 68 weeks.
Individual results vary based on adherence, diet, exercise, and metabolic health. Patients who combine Fridays’ medication with the included dietitian coaching tend to report better outcomes than those who rely on medication alone. The lifestyle coaching component is designed to amplify the appetite suppression effect.
No specific weight loss guarantees are provided by Fridays. The platform presents clinical evidence for the medications rather than program-specific outcome data. Patients should align expectations with published GLP-1 trial results rather than marketing claims.
Is Fridays Safe?
Yes. Fridays employs board-certified physicians and licensed providers who review patient health history, monitor progress through regular video consultations, and require lab work before and during treatment. The medical oversight model reduces the risk of inappropriate prescribing. Clinical screening excludes patients with contraindications before medications are dispensed.
Compounded semaglutide and tirzepatide carry the same risk profile as their FDA-approved brand-name counterparts. Side effects include nausea, vomiting, diarrhea, and a black box warning for thyroid C-cell tumor risk. These risks are disclosed during the clinical consultation process.
The FDA has flagged compounded GLP-1 medications as a category requiring caution — compounded drugs are not FDA-approved and may vary in purity or potency across compounding pharmacies. Fridays uses licensed compounding pharmacies, but patients should understand that compounded formulations fall outside the FDA’s standard approval pathway.
What Are the Side Effects of Fridays Medications?
Fridays medications carry the standard GLP-1 side effect profile — nausea, vomiting, diarrhea, and abdominal discomfort are most common, particularly during the first 2-4 weeks of treatment. These effects are shared by all GLP-1 and dual GLP-1/GIP agonist medications. The severity depends on starting dose, individual sensitivity, and escalation pace.
The good news? Fridays’ microdosing protocol is specifically designed to minimize early GI side effects. Starting at a lower dose gives the GI tract time to adjust before escalating to therapeutic levels. Patients who use the microdosing pathway report fewer and less intense side effects in early weeks.
Serious adverse events include pancreatitis, thyroid C-cell tumors (black box warning), and hypoglycemia when combined with sulfonylureas. These risks are present for both semaglutide and tirzepatide. The Fridays clinical team screens for contraindications before prescribing to minimize exposure to serious adverse events.
What Are Common GLP-1 Side Effects?
GLP-1 medications most commonly cause nausea (affecting 15-25% of patients), diarrhea (10-15%), vomiting (8-12%), and decreased appetite — all driven by slowed gastric emptying and altered gut hormone signaling. These effects are temporary in most patients. Severity peaks in the first 2-4 weeks and typically resolves as the body adapts to the medication.
Taking GLP-1 medications with food reduces nausea severity. Small, frequent meals with reduced fat content minimize GI discomfort during the adjustment period. Adequate hydration further reduces symptom intensity during the early weeks of treatment.
Most patients find side effects manageable with dose adjustments and dietary modifications. Patients who cannot tolerate side effects at any dose should contact their Fridays provider. Dose reduction, medication switching, or program discontinuation are options available through the ongoing video visit system.
Common GLP-1 side effects by frequency:
- Nausea (15-25% of patients)
- Diarrhea (10-15% of patients)
- Vomiting (8-12% of patients)
- Constipation (5-10% of patients)
- Abdominal pain and bloating
- Injection site discomfort
Who Should Avoid Fridays?
Fridays excludes patients with a personal or family history of medullary thyroid carcinoma, MEN2 syndrome, or active pancreatitis — these represent absolute contraindications to GLP-1 medications that Fridays’ clinical screening process identifies. Pregnant patients and those planning pregnancy are also excluded. GLP-1 medications are not studied in pregnant populations and are classified as requiring discontinuation before or upon pregnancy discovery.
Patients with severe kidney or liver disease may not be eligible depending on clinical assessment. The Fridays intake process flags these conditions for provider review. Eligibility decisions are made on a case-by-case basis by board-certified physicians.
Adults with a BMI below 25 fall outside Fridays’ primary eligibility criteria. The BMI threshold reflects standard clinical guidelines for GLP-1 weight loss prescribing. Patients near the threshold should complete the intake form and allow the provider to make the final eligibility determination.
What Do Fridays Reviews Say?
Fridays has over 1,000 five-star reviews on TrustPilot — a strong signal of customer satisfaction relative to most telehealth competitors in the GLP-1 space. The overwhelming majority of positive reviews cite three factors: fast onboarding, responsive customer service, and real weight loss results. Negative reviews are the minority but follow a consistent pattern.
To be clear: independent reviews from outlets like Forbes and Yahoo Lifestyle note that the Fridays website is confusing regarding which medications are available and how insurance interacts with the program. This information clarity issue is a documented weak point. However, customer service response time under 10 minutes was praised across multiple independent reviews.
Review sentiment is generally stronger among patients who use the coaching and dietitian services alongside medication. Patients who treat Fridays as a medication-only delivery service without engaging the lifestyle support report less satisfaction and slower results.
What Are Positive Fridays Experiences?
Positive Fridays reviewers consistently highlight the speed and simplicity of the onboarding process, with many patients receiving medication within days of completing their first consultation. The all-inclusive pricing model receives frequent praise — patients appreciate knowing the full cost upfront without surprise fees for labs or follow-up visits.
The microdosing option is cited as a key differentiator by patients who previously failed other GLP-1 programs. Users who struggled with nausea on Ozempic or standard semaglutide doses report successfully tolerating Fridays’ gradual escalation approach. This flexibility converts program failures from other platforms into Fridays success stories.
The dietitian and mental health coaching components receive positive feedback from patients who engage with them. Users report that having an expert to navigate dietary adjustments during GLP-1 treatment accelerates their results. The SESH fitness app integration is mentioned as a helpful bonus by physically active members.
What Are Common Fridays Complaints?
The most common Fridays complaint is website clarity. Multiple independent reviewers note difficulty understanding which medications are available, how pricing works across different plans, and what insurance or HSA reimbursement options apply. Interesting problem for a health platform. But customer service resolves most confusion quickly.
Some users report shipping delays with compounded medications. Compounding pharmacy processing times add variability to delivery schedules. Patients who expect consistent weekly delivery cycles occasionally report gaps between refills during high-demand periods.
Cost is flagged as a concern by patients without insurance or HSA/FSA access. At $129/month and above, Fridays is not the cheapest GLP-1 telehealth option. Patients comparing cash-pay options find that some competitors offer lower monthly medication costs without the bundled coaching services.
How Much Does Fridays Cost?
Fridays starts at $129 per month with medications included — a flat-fee pricing model that bundles GLP-1 medication, unlimited video visits, unlimited labs, dietitian coaching, and fitness app access. No membership fees or hidden add-ons apply to the base plan. The starting price covers the core program components for a single medication tier.
Higher-dose or tirzepatide-based plans carry different pricing than the entry-level semaglutide option. Exact pricing for each tier varies and should be confirmed directly with Fridays during intake. The $129 starting point represents the lowest available entry into the program.
Fridays accepts HSA and FSA funds for reimbursement. This makes the program accessible to patients with pre-tax healthcare spending accounts, effectively reducing the after-tax cost. Medicare and Medicaid are not accepted — the platform operates on a cash-pay model only.
Does Insurance Cover Fridays?
No. Fridays is a cash-pay telehealth service that does not accept insurance for program fees or medication costs — patients pay out-of-pocket, though HSA and FSA reimbursement is accepted. The cash-pay model avoids insurance prior authorization delays, which can significantly slow access to GLP-1 medications through traditional insurance channels.
HSA and FSA funds can cover GLP-1 program costs when prescribed for a medical condition. Patients with employer-sponsored flexible spending accounts or health savings accounts should confirm eligibility with their plan administrator. Documentation from the Fridays provider can support reimbursement claims.
The insurance exclusion is a significant barrier for some patients. Branded GLP-1 medications like Ozempic and Wegovy can exceed $1,000/month without coverage. Fridays’ compounded alternatives at $129+ per month represent a more accessible price point for the uninsured population seeking GLP-1 weight loss treatment.
Fridays cost comparison:
| Option | Monthly Cost | Insurance | Medications Included |
|---|---|---|---|
| Fridays (entry plan) | $129 | No (HSA/FSA OK) | Yes |
| Branded Ozempic (no ins.) | $800-1000 | T2D required | N/A |
| Branded Wegovy (no ins.) | $1300-1400 | Obesity approval | N/A |
| Other GLP-1 telehealth | $150-400 | No | Varies |
Is Fridays Legit?
Yes. Fridays is a legitimate telehealth platform operated by board-certified physicians and licensed healthcare providers, with over 1,000 verified TrustPilot reviews and recognition from major health publications. The company is not a scam. Medications are dispensed only after a licensed clinical review — not automatically issued based on an online form alone.
The use of compounded rather than branded FDA-approved medications is a point of transparency worth noting. Compounded semaglutide and tirzepatide contain the same active ingredients as Ozempic and Mounjaro but are manufactured by compounding pharmacies rather than the original drug manufacturers. The FDA does not approve compounded drugs individually, though the active ingredients are FDA-approved compounds.
Fridays is featured in Forbes, Yahoo Lifestyle, and other credible media outlets. The editorial coverage is independent, not sponsored. Media recognition of this nature does not guarantee program outcomes but reflects legitimate operation as a healthcare business in the regulated telehealth space.
Should You Try Eat Proteins with Your Fridays Program?
Eat Proteins provides the high-protein nutrition framework that maximizes GLP-1 results — Fridays suppresses appetite, but what you eat during that reduced hunger window determines whether you lose fat or muscle. Most Fridays members reduce total calories without optimizing protein intake. Muscle loss during GLP-1-driven caloric reduction is a documented clinical concern.
Our experts at Eat Proteins work with patients on GLP-1 programs to build nutrition plans that preserve lean mass while the medication handles appetite suppression. Protein targets, meal timing, and food selection strategies are tailored to the GLP-1 treatment context. The coaching complements what Fridays provides — it doesn’t replace it.
You’re already investing in Fridays. Don’t undercut it by leaving nutrition unstructured. The Eat Proteins approach turns GLP-1 appetite reduction into targeted fat loss instead of mixed fat-and-muscle loss. Sustainable body composition change requires both the right medication and the right protein strategy.